http://www.maps.org/
The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership–based, IRS–approved 501 (c) (3) nonprofit research and educational organization. Our mission is 1) to treat conditions for which conventional medicines provide limited relief—such as posttraumatic stress disorder (PTSD), pain, drug dependence, anxiety and depression associated with end-of-life issues—by developing psychedelics and marijuana into prescription medicines; 2) to cure many thousands of people by building a network of clinics where treatments can be provided; and 3) to educate the public honestly about the risks and benefits of psychedelics and marijuana.
Fascinating, I was all set to sign up and pack a bag, before reading that the LSD study is only for participants with terminal conditions. Don’t they know that not everybody dying to know what relief could be wrought is actually dying in an imminent sense? Grumpy grumble aside, I’m glad that those who do meet the criteria and participate have the opportunity of this unique palliative care available to them.
Added note: I’d rather conduct my own explorations without a bunch of lab coated note takers peering and scribbling. Still, it's great that they're exploring this.
Who knows what the CIA is ever up to, but it’s been a long pause between academic studies like this in the U.S.